🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/09/2006 | 39,58 | 40,30 | 39,56 | 40,22 | +2,08% | 1,86% | 9.654.176 |
| 11/09/2006 | 38,84 | 39,48 | 38,84 | 39,40 | +0,56% | 1,65% | 5.214.429 |
| 08/09/2006 | 38,07 | 39,38 | 38,07 | 39,18 | +1,03% | 3,43% | 5.173.557 |
| 07/09/2006 | 39,50 | 39,55 | 38,65 | 38,78 | -1,84% | 2,29% | 7.264.841 |
| 06/09/2006 | 39,13 | 39,59 | 38,86 | 39,50 | +0,56% | 1,88% | 7.874.358 |
| 05/09/2006 | 39,11 | 39,30 | 38,74 | 39,28 | +0,51% | 1,44% | 6.704.999 |
| 01/09/2006 | 38,66 | 39,15 | 38,51 | 39,08 | +1,01% | 1,65% | 5.997.390 |
| 31/08/2006 | 38,94 | 39,09 | 38,50 | 38,69 | -0,61% | 1,52% | 7.249.750 |
| 30/08/2006 | 39,06 | 39,36 | 38,84 | 38,93 | -1,14% | 1,34% | 8.223.656 |
| 29/08/2006 | 39,03 | 39,48 | 38,87 | 39,38 | +0,78% | 1,54% | 11.130.808 |
| 28/08/2006 | 38,41 | 39,33 | 38,37 | 39,07 | +1,26% | 2,51% | 9.309.279 |
| 25/08/2006 | 37,98 | 38,86 | 37,98 | 38,59 | +0,95% | 2,34% | 8.289.051 |
| 24/08/2006 | 38,95 | 39,01 | 38,12 | 38,23 | -0,99% | 2,28% | 12.591.720 |
| 23/08/2006 | 38,02 | 38,73 | 37,96 | 38,61 | +1,79% | 2,03% | 11.306.243 |
| 22/08/2006 | 37,77 | 38,41 | 37,74 | 37,93 | +0,25% | 1,77% | 10.208.673 |
| 21/08/2006 | 38,17 | 38,36 | 37,62 | 37,83 | +0,33% | 1,93% | 13.137.728 |
| 18/08/2006 | 36,83 | 38,00 | 36,59 | 37,71 | +1,78% | 3,81% | 22.871.657 |
| 17/08/2006 | 39,41 | 39,82 | 36,26 | 37,05 | -5,71% | 9,03% | 38.334.897 |
| 16/08/2006 | 39,36 | 39,52 | 39,09 | 39,29 | +0,56% | 1,09% | 7.193.262 |
| 15/08/2006 | 39,34 | 39,50 | 39,01 | 39,07 | +0,17% | 1,26% | 10.064.678 |
| 14/08/2006 | 38,98 | 39,41 | 38,85 | 39,01 | +0,69% | 1,44% | 7.051.258 |
| 11/08/2006 | 39,07 | 39,17 | 38,57 | 38,74 | -1,77% | 1,54% | 8.833.802 |
| 10/08/2006 | 39,31 | 39,53 | 38,99 | 39,44 | -0,31% | 1,38% | 7.004.937 |
| 09/08/2006 | 39,12 | 39,80 | 39,11 | 39,56 | +1,17% | 1,76% | 9.845.331 |
| 08/08/2006 | 39,13 | 39,39 | 38,84 | 39,10 | +0,34% | 1,41% | 8.638.769 |
| 07/08/2006 | 39,46 | 39,57 | 38,32 | 38,97 | -1,23% | 3,17% | 8.981.046 |
| 04/08/2006 | 39,73 | 39,87 | 39,09 | 39,46 | -0,58% | 1,95% | 8.086.892 |
| 03/08/2006 | 39,23 | 39,85 | 38,90 | 39,69 | +1,36% | 2,41% | 10.418.168 |
| 02/08/2006 | 38,93 | 39,21 | 38,81 | 39,15 | +0,51% | 1,03% | 10.736.760 |
| 01/08/2006 | 38,53 | 39,21 | 38,34 | 38,95 | +1,37% | 2,25% | 10.332.861 |